Abstract
The complex etiologies and mechanisms of cell death associated with, as well as protective/reparative techniques for several neurodegenerative disorders, have been examined using animal models. We have witnessed during the last 5 yr advances in gene knockout animal models and how these animal systems can pave the way for better understanding of human diseases. For example, the discovery of the gene underlying Huntington’s disease (HD) opens the possibility that genetic therapy may be the next logical step toward finding a cure for this disease. HD is a progressive debilitating disorder associated with severe degeneration of basal ganglia neurons, especially the intrinsic neurons of the striatum, and characterized by involuntary abnormal choreiform movements and progressive dementia. In this chapter, cross-species models of HD are discussed, which recently received critical attention from researchers interested in the involvement of impaired energy metabolism in the evolution of the disease. The preceding chapters dealt largely with the utility of rodent model of 3-nitropropionic acid (3-NPA), which has been demonstrated as closely resembling the neurobiological and clinical symptoms of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR. Behav-ioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington’s disease. Brain Res 1996a; 697: 254–257.
Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR. Systemic 3-nitropropionic aicd: behavioral deficits and striatal damage in rats. Brain Res Bull 1995; 36: 549–556.
Koutouzis TK, Borlongan CV, Scorcia TA, Sanberg PR. Systemic 3-nitropropionic acid: long-term effects on locomotor behavior. Brain Res 1994a; 646: 242–246.
Koutouzis TK, Borlongan CV, Freeman TB, Sanberg PR. Intrastriatal 3-nitropropionic acid: a behavioral assessment. NeuroReport 1994b; 5: 2241–2245.
Borlongan CV, Nishino H, Sanberg PR. Systemic but not intraparenchymal administration of 3-nitropropionic acid mimics the neuropathology of Huntington’s disease: a speculative explanation. Neurosci Res 28: 185–189, 1997.
Sanberg PR, Calderon SF, Girodano M, Tew JM, Norman AB. The quinolinic acid model of Huntington’s disease: Locomotor abnormalities. Exp Neurol 1988; 105: 45–53.
Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF. Chronic mitochondrial enegy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 1995; 92: 7105–7109.
Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 1993; 60: 356–359.
Ferrante RJ, Hantraye P, Brouillet E, Kowall NW, Beal MF. Striatal pathology of impaired mitochondrial metabolism in primate profiles of Huntington’ s disease. Soc Neurosci Abstr 1993; 19: 408.
Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington’s disease. J Neurosci 1996; 16: 3019–3025.
Palfi S, Riche D, Brouillet E, Guyot MC, Mary V, Wahl F, Peschanski M, Stutzmann JM, Hantraye P. Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration. Exp Neurol 1997; 46: 135–141.
Dong J, Shear DA, Gundy CD, Creguer-Haik K, Dunbar GL. Behavioral and histological comparisons of two animal models of Huntington’s disease. Soc Neurosci Abstr 1996; 22: 227.
Borlongan CV, Koutouzis TK, Poulos SG, Saporta S, Hauser RA, Cahill DW, Freeman TB, Sanberg PR. Bilateral intrastriatal transplantation of rat fetal striatal tissue into the 3-nitropropionic acid rat model of Huntington’s disease. Soc Neurosci 1996; 22: 580.
Yanai J, Silverman WF, Shamir D. An avian model for the reversal of 6hydroxydopamine induced rotating behaviour by neural grafting. Neurosci Lett 1995; 187: 153–156.
Butler AB, Hodos W. Comparative Vertebrate Neuroanatomy Evolution and Adaptation. Wiley-Liss, New York, 1996.
Borlongan CV, Koutouzis TK, Jorden JR, Martinez R, Rodriguez AI, Poulos SG, Freeman TB, McKeown P, Cahill DW, Nishino H, Sanberg PR. Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci Biobehav Rev 1997; 21: 79–90.
Youdim MB, Dhariwal K, Levine M, Markey CJ, Markey S, Caohuy H, Adeyemo OM, Pollard HB. MPTP-induced “Parkinsonism” in the goldfish. Neurochem Int 1992; 20 (Suppl): 275–278.
Pollard HB, Dhariwal K, Adeyemo OM, Markey CJ, Caohuy H, Levine M, Markey S, Youdim MB. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. FASEB J 1992; 6: 3108–3016.
Adeyemo OM, Youdim MB, Markey SP, Markey CJ, Pollard HB. L-deprenyl confers specific protection against MPTP-induced Parkinson’s disease-like movement disorder in the goldfish. Eur J Pharmacol 1993; 240: 185–193.
Pollard HB, Kuijpers GA, Adeyemo OM, Youdim MB, Goping G. The MPTPinduced Parkinsonian syndrome in the goldfish is associated with major cell destruction in the forebrain and subtle changes in the optic tectum. Exp Neurol 1996; 142: 170–178.
Sullivan SA, Barthel LK, Largent BL, Raymond PA. A goldfish Notch-3 homologue is expressed in neurogenic regions of embryonic adult and regenerating brain and retina. Dev Genet 1997; 20: 208–223.
Hanna GF, Nawar NN, Sharma SC. Regeneration of ascending spinal axons in goldfish. Brain Res 1998; 791: 235–245.
Jian X, Szaro BG, Schmidt JT. Myosin light chain kinase: expression in neurons and upregulation during axon regeneration. J Neurobiol 1996; 31: 379–391.
Heacock AM, Agranoff BW. Protein kinase inhibitors block neurite outgrowth from explants of goldfish retina. Neurochem Res 1997; 22: 1179–1185.
Giordano S, Laessing U, Ankerhold R, Lottspeich F, Stuermer CA. Molecular characterization of E587 antigen: an axonal recognition molecule expressed in the goldfish central nervous system. J Comp Neurol 1997; 377: 286–297.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Borlongan, C.V., Shimizu, T., Sanberg, P.R. (2000). Comparative Study on 3-Nitropropionic Acid Neurotoxicity. In: Sanberg, P.R., Nishino, H., Borlongan, C.V. (eds) Mitochondrial Inhibitors and Neurodegenerative Disorders. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-692-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-692-8_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9821-9
Online ISBN: 978-1-59259-692-8
eBook Packages: Springer Book Archive